Effective Wednesday, August 17, 2022, the Coagulation Department at Spectrum Health Reference Laboratory (SHRL) will go-live with the Epic orderable APTT Direct Thrombin Inhibitor [LAB1230880].
Browsing Tag
Jennifer Stumph
General Information, Immunochemistry, Main lab, Test Utilization
Protein Electrophoresis Testing Update
In December, serum and urine protein electrophoresis testing will be simplified and standardized. The only testing available will be:
Protein electrophoresis, serum, IFE if indicated
Protein electrophoresis, random urine, do IFE if indicated
Protein electrophoresis, 24 hour urine, do IFE if indicated
In addition, on December 5, 2019, a new panel will be added which reflects expert recommendations for first line testing for monoclonal gammopathy, including plasma cell myeloma and most cases of amyloidosis, called “Monoclonal Gammopathy Screen”
Effective November 5th, testing for Beta-2 Glycoprotein 1 antibodies (IgG and IgM, serum) will change from a reference send out test to Mayo Medical Laboratories to an in-house test available at Spectrum Health Laboratories. This testing is useful for evaluation of patients of suspected antiphospholipid antibody syndrome.
In addition, a new Antiphospholipid Antibody Syndrome Panel will be added which allows for appropriate and complete testing for antiphospholipid antibody syndrome. This panel includes:
Lupus Screen
Cardiolipin IgG and IgM Antibodies
Beta-2 Glycoprotein 1 IgG and IgM Antibodies
Effective Monday, March 25, 2019, Syphilis Antibody Screen IgG [LAB3076] will change to Syphilis Total Antibody Screen [LAB1230501]. This test is also included in the Prenatal Screen (OB Panel) [LAB1230094].
Spectrum Health has been informed by Roche Diagnostics that the proprietary reagents used to calibrate our instruments and determine control values for ferritin blood level have been updated to reflect deviation of results leading to low result bias. This may have led to patient results being up to 20% lower than actual ferritin level.
Chemistry, Compliance & Safety, General Information
Reference Range Update – OB Magnesium, Blood Level
Effective immediately, the OB Magnesium (Mg) reference range has been updated from 1.6 to 2.5 mg/dL to 4.8 to 8.0 mg/dL, to reflect the correct therapeutic range for patients receiving magnesium sulfate therapy. The non-OB magnesium reference range is unchanged.
Please direct questions and inquiries to Dr. Jennifer Stumph via the Contact Us link above.
TEST INFORMATION
OB Magnesium, Blood Level – Epic code #LAB3400, Interface code #11703, CPT code #83735